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The outer membrane (OM) of Gram-negative bacteria is a unique asymmetric lipid bilayer in 
which the outer leaflet is composed of lipopolysaccharide (LPS) and the inner leaflet is formed by 
glycerophospholipid (GPL). The OM plays a fundamental role in protecting Gram-negative bacteria from 
harsh environments and toxic compounds. The transport and assembly pathways for phospholipids of 
bacterial OM are unknown. Cardiolipin (CL) plays an important role in OM biogenesis and pathogenesis, 
and the inner membrane (IM) protein PbgA, containing five transmembrane domains and a globular 
domain in periplasm has been recently identified as a CL transporter from the IM to the OM with an 
unknown mechanism. Here we present the first two crystal structures of soluble periplasmic globular 
domain of PbgA from S. typhimurium and E. coli, which revealed that the globular domains of PbgA 
resemble the structures of the arylsulfatase protein family and contains a novel core hydrophobic 
pocket that may be responsible for binding and transporting CLs. Our structural and functional studies 
shed an important light on the mechanism of CL transport in Gram-negative bacteria from the IM to the 
OM, which offers great potential for the development of novel antibiotics against multi-drug resistant 
bacterial infections.
Gram-negative bacteria contain two membranes, the inner membrane (IM) and the outer membrane (OM) with 
the solvent filled periplasm and the peptidoglycan1,2. The peptidoglycan, which is much thinner than that found 
in Gram-positive bacteria, is bound to the OM by lipoproteins, but it remains strong and elastic to protect the 
bacteria against harsh environmental conditions2,3. The OM is an asymmetric lipid bilayer in which the inner 
leaflet is composed of glycerophospholipids (GPL) while the outer leaflet consists primarily of the glycolipid 
lipopolysaccharide (LPS), which functions as a barrier protecting bacteria from antibiotics and other harmful 
hydrophobic chemicals1,2,4,5. The OM also contains OM proteins and lipoproteins. The pathways of transport 
and assembly of LPS, lipoprotein and OMP from the IM to the OM have been identified and studied extensively; 
seven proteins LptA-G form a trans-envelope complex and transport LPS from the IM to the OM1,2,6–13. Five 
proteins LolA-E are responsible for sorting and transporting lipoproteins from the IM to the OM14–17, while five 
proteins BamA-E form a OMP insertion machine, which inserts unfolded OMP into the OM18–22. The proteins 
involved in phospholipid transport and assembly in the OM, however remain unknown.
In contrast, the IM is a symmetrical bilayer and is composed of phospholipids that maintain the barriers’ per-
meability for hydrophilic molecules and support the functions of the IM proteins3. The GPL molecules include 
phosphatidylethanolamine (PE), phosphatidylglycerols (PG) and cardiolipin (CL) in an approximately 75:20:5 
ratio, respectively, in most enterobacterial membranes. CL is also known as diphosphatidylglycerol because it 
appears to contain two overlapping PG units (Supplementary Fig. S1). CL is also located in the OM of most 
Gram-negative bacteria, where it is essential for bacterial pathogenesis and survival in different environments 
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under the regulatory control of the PhoPQ two-component system23,24. However, CL is synthesized at the IM, and 
so must be transported by lipid transfer proteins from the IM to the OM25,26.
Interestingly, CL is also presented in the IM of mitochondria, where it consists of about 20% of the total lipids, 
and is required for the mitochondrial function27,28. In yeast, the UPS1 and Mdm35 complex has been identi-
fied to transport phosphatidic acid (PA) from the mitochondria OM to the IM, and the structure of the UPS1 
and Mdm35 complex has been recently solved29,30. In Gram-negative bacteria the Mla pathway, containing six 
proteins MlaA-F, has been suggested to be responsible for phospholipids transport from the OM to the IM31. In 
addition, the trigalactosyldiacylglycerol (TGD) pathway has been reported to deliver phosphatidic acid from the 
OM to the IM of chloroplasts32. However, there is no report about how the phospholipids are transported and 
assembled from the IM to the OM.
During infection, Salmonella typhimurium and Escherichia coli PhoPQ two-component regulatory system 
coordinates OM remodeling by activating genes encoding proteins and enzymes that increase OM-lipid hydro-
phobicity and decrease OM-lipid negative charge on the bacterial surface; this prevents binding and insertion 
of cationic antimicrobial peptides (CAMP) that kill the microbe23. S. typhimurium PbgA is an inner membrane 
protein containing five transmembrane helices and a globular periplasmic domain, which binds CL to promote 
PhoPQ-regulated trafficking of CL from the IM to the OM24.
Here we present the crystal structures of the globular domain of PbgA from S. typhimurium and E. coli, as 
well as functional assays. The structures and functional assays revealed the molecular basis of how the globular 
domain transports CL from the IM to the OM. To our knowledge, this is the first protein structure reported 
involved in phospholipid transport from the IM to the OM in bacteria.
Results
Two structures of PbgA. The PbgA (the original name YejM) protein was predicted to be an inner mem-
brane protein containing five transmembrane domains (residues 1–190) and a C-terminal globular domain (res-
idues 191–586) (Fig. 1a). To crystallize the PbgA proteins, the full length PbgA proteins and two N-terminal 
transmembrane domains truncation constructs (residues 191–586, and 245–586) named PbgA191-586 
and PbgA245-586, from S. typhimurium Strain LT2 and E. coli K12 were cloned into pHISTEV plasmids. All 
the proteins were purified, and the PbgA245-586 from S. typhimurium Str. LT2 (StPbgA245-586) and E. coli 
(EcPbgA245-586) were crystallized, while the purified PbgA191-586 showed degradation and crystallized with 
Figure 1. Two crystal structures of cardiolipin transport protein PbgA. The structures of PbgA resemble 
those of arylsulfatases and lipoteichoic acid synthases. (a) Scheme of PbgA of S. typhimurium strain LT2.  
(b) Cartoon representation of crystal structure of StPbgA245-586. The PbgA structure is colored in rainbow.  
(c) Cartoon representation of crystal structure of ECPbgA245-586 in green. (d) Scheme representation of 
structure of StPbgA245-586.
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in situ limited proteolysis using elastase (Supplementary Fig. S2a,b). The crystal of StPbgA254-586 belongs to 
space group P21 with cell dimensions a = 51.60 Å, b = 196.09 Å, c = 70.27 Å, α = γ = 90° and β = 95.70° (Table 1). 
The structure of StPbgA245-586 was determined to 1.64 Å resolution by single-wavelength anomalous dispersion 
(SAD) using selenomethionine (SeMet) incorporated protein. 28 selenium positions were identified in an asym-
metric unit using SHELXD33. The electron density map was modified by SHELXE34,35. The initial model was built 
by Buccaneer36, and the full model was built manually using Coot37. Structure refinements were performed using 
REFMAC5 with the final model with the Rfactor of 0.19 and Rfree of 0.22 (Table 1).
There are four protomers of the StPbgA245-586 in the asymmetric unit. The structure of protomer A in the 
asymmetric unit is very similar to the other three protomers, B, C and D, with root-mean-square deviations 
(RMSD) of 0.285, 0.472 and 0.451 Å over 338 Cα atoms, respectively. The model of the StPbgA245-586 contains 
residues Q245-I563 and P568-A585, while the electron densities of the loop between I563-P568 are not visible, 
indicating that this loop is disordered (Fig. 1b,d).
The structure of StPbgA245-586 has the α /β fold, which looks like a burger, where helices α 1, α 6 and α 7 are at 
the top, β -strands 1, 2, 3, 4, 5, 6, 7, 8, α 8 and α 9 form the second layer, α -helices 2, 4, 5 and 10 form the third layer, 
and β -strands 8, 9, 10, 11, α 11 and α 12 form the bottom layer (Fig. 1b).
The crystals of StPbgA191-586 belong to the space group P21 with cell dimensions a = 41.49 Å, b = 196.39 Å, 
c = 45.66 Å, α = γ = 90° and β = 107.53°. The StPbgA191-586 structure was determined by molecular replacement 
to 2.19 Å resolution; residues 191–245 has no visible electron density so were either disordered or cleaved. There 
are four protomers in the asymmetric unit, where the protomer A is superimposed well with protomers B, C and 
D with RMSD of 0.2642 Å, 0.4338 Å and 0.5627 Å over 340 Cα atoms, respectively. The StPbgA191-586 structure 
is very similar to StPbgA245-586 structure with RMSD of 0.5945 over 340 Cα atoms (Supplementary Fig. S3a,b).
The crystals of EcPbgA245-586 belong to the space group of P3121 with cell dimensions a = b = 56.86 Å, 
c = 191.81 Å, α = β = 90° and γ = 120° (Table 1). The structure was determined by molecular replacement using 
the StPbgA245-586 structure as the search model to 1.67 Å resolution (Fig. 1c). There is one monomer in the 
asymmetric unit. The EcPbgA-245-586 structure resembles StPbgA254-586 structure with a RMSD of 0.9264 Å 
over 340 Cα atoms. In particular, the β 4 of EcPbgA-245-586 moves away approximately 8 Å (Fig. 2a,b).
PbgA resembles arylsulfatase family proteins and lipoteichoic acid synthase. To find sim-
ilar structures to PbgA, we performed searches in the Protein Data Bank using the Dali server using the 
StPbgA245-586 structure as the template. The PbgA structure is very similar to sulfatase family enzymes, where 
arylsulfatase (PDB code 1HDH)38 has the Dali-score of 29.9 with root-mean-square deviation (RMSD) of 2.9 Å 
over 296 Cα atoms to the StPbgA245-586 structure (Fig. 3a). The sulfatases hydrolyse a variety of sulphate esters 
Data collection EcPbgA245 StPbgA191 StPbgA245 (SAD)
Resolution (Å) 47.83–1.67 (1.71 − 1.67) 65.22–2.19 (2.25–2.19) 65.85–1.64 (1.68 − 1.64)
Wavelength (Å) 0.9795 0.9795 0.9795
Space Group P3121 P21 P21
Completeness (%) 99.6 (99.2)* 99.4 (99.4) 95.1 (89.2)
I/σ 17.8 (1.1) 5.8 (1.8) 15.5 (1.1)
Multiplicity 9.6 (7.6–9.9) 6.1 (6.4–4.8) 11.8 (13.1–6.1)
CC1/2 (%) 100 (59.5) 98.7 (54.5) 99.9 (49.5)
Unique reflections 44003 (4034) 51747 (5044) 66831 (6540)
Rmerge (%) 14.3 (26.40) 16.50 (27.80) 15.2 (25.03)
Unit Cell (Å) a = b = 57.42, c = 191.31 a = 51.48 b = 195.65, c = 70.92 a = 51.60 b = 196.09, c = 70.27
α = β = 90°, γ = 120° α = γ = 90°, β = 96.39° α = γ = 90°, β = 95.79°
Refinement
&Rfactor 0.18 (0.21) 0.20 (0.23) 0.19 (0.20)
Rfree 0.21 (0.25) 0.24 (0.27) 0.22 (0.24)
Number of atoms
Protein 2604 10724 10745
Waters 498 961 1243
R.M.S. deviation 
Bond lengths (Å) 0.014 0.02 0.017
Bond angles (°) 1.90 1.93 1.80
Ramachandran statistics
Favoured (%) 97 93 95
Allowed (%) 3 7 5
PDB code 5I5H 5I5F 5I5D
Table 1.  Data collection and structure refinement statistics. * Values in parentheses are represents for 
the highest-resolution shell. &Rfactor = Σ || Fobs|−| Fcal||/Σ |Fobs|, where Fobs and Fcal are observed all reflection 
measured and calculated currently model as structure factors, respectively. Rfree is calculated using 5% of total 
reflections, which is randomly selected not used in refinement.
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utilising an active site containing Cα -formylglycine, a conserved and oxidized cysteine or serine residue, and 
metal binding residues D317, N318, D13 and D14 (PDB code 1HDH) (Fig. 3b). Although the overall struc-
ture is similar by superimposition of the two structures, StPbgA245-586 does not have the cysteine or serine at 
the position of the Cα -formyglycine of the sulfatase. We also did not observe any cysteine or serine residue of 
StPbgA245-586 around the position of the sulfatase’s active site. Instead, the StPbgA245-586 structure has res-
idues T302, G450, R451, G269 and D268 at the corresponding positions in the sulfatase active site, respectively 
(Fig. 3a,b); this is consistent with the report that the PbgA does not have the sulfatase activity24. The major differ-
ences between the two structures are that the sulfatase has additional α -helices38 and loops that form a “gate” to 
close the active site (Fig. 3a).
The structure of lipoteichoic acid synthase of Staphylococcus aureus (LtaS, PDB code 2W5T)39, is also 
very similar to the StPbgA245-586 structure, with the Dali score of 28.4 and a RMSD of 3.0 Å over 284 Cα 
atoms. Despite only 17% sequence identity to StPbgA, LtaS is also a membrane protein with five transmem-
brane domains and a globular soluble domain with a structure strikingly similar to the StPbgA245-586 struc-
ture (Fig. 3c). The LtaS structure has revealed the active site pocket for binding a Mn2+ ion and Beta-Glycerol 
pho-sphate (sn-glycerol-2-phosphate), where residues T300, H476 and E255 bind Mn2+ ion, and H416, W354, 
F353, D349, H347 and R356 are involved in the Beta-Glycerol pho-sphate (sn-glycerol-2-phosphate) binding 
(Fig. 3c,d). As described above, the corresponding residues T302, G450, R451 and D268 of StPbgA are unlikely to 
form the metal binding site (Mn2+). The residues H347, D349, R356 and W354 of LtaS involving in Beta-Glycerol 
pho-sphate (sn-glycerol-2-phosphate) binding were confirmed to be important for the activity of LtaS39. The 
arrangement of the corresponding residues N403, S345, D347, A350 and Y354 of StPbgA does not correspond to 
the Beta-Glycerol pho-sphate (sn-glycerol-2-phosphate) binding site (Fig. 3d).
StPbgA245-586 does not bind metal ions and Beta-Glycerol pho-sphate (sn-glycerol- 
2-phosphate). To confirm whether StPbgA245-586 binds heavy atoms and Beta-Glycerol pho-sphate 
(sn-glycerol-2-phosphate), we have performed co-crystallization the StPbgA245-586 in presence of the 20mM 
Mn2+ and 20 mg/ml sn-glycerol-2-phosphate. However, no extra electron density is visible in the solved structure, 
suggesting that PbgA may not bind metal or sn-glycerol-2-phosphate. 
Potential CL binding site. From the structures of the sulfatase and LtaS, their active sites are between the 
second layer and the third layer. In PbgA, the second layer consists of the β -sheet formed by strands 1–7 and the 
third layer is composed of of α -helices 2, 4, 5 and 10. This region is a highly hydrophobic core, which is formed by 
the hydrophobic residues L343, W396, F394, V262, W477, L473, V471, and F292 from the β -sheet of the second 
layer, and residues F349, Y354, L334, F310, L309, and F519 from the α -helices and loops of the third layer (Fig. 4a,b). 
PbgA transports CL from the IM to the OM24. We speculate that the hydrophobic core between the second and third 
layers might be the CL binding site. To explore this possibility, single alanine substitutions of residues L359, F292, 
F349, F519, L334, L343, F394, W396, V471 and W477, as well as a double alanine substitution R215/R216, were 
generated, and the PbgA global domain (191–586) inactivated strain NRD183 was used for the functional assay40.
The deletion of PbgA periplasmic globular domain causes the outer membrane defect, which increases the OM 
permeability. The NRD183 strain was unable to grow in 50 μ g/ml vancomycin, and the full length PbgA can rescue the 
NRD183 strain. The F292A mutant is lethal, and F349A, R215A/R216A, W396A, F362A and F275A severely impaired 
bacterial growth in 50 μ g/ml vancomycin (Fig. 4e,g,h), while mutants L343A, F394A, V471A, W477A have minor effect 
on cell growth (Fig. 4f), and F310A, Y354A, L359A has no effect on cell growth (Fig. 4i), suggesting that residues F292, 
F349, R215/R216, W396, F362 and F275 are important for CL transport. The functional assay result of R215A/R216A 
mutant is consistent with the previous report that the residues R215/R21624 are involved in CL binding (Fig. 4e).
Residues F344, W379, W393 and F399 are located in the hydrophobic core between the α -helices 6 and 7 
of the first layer and the β -strands 1 and 4 of the second layer of EcPbgA (Fig. 4c,d). In contrast, single mutant 
Figure 2. Comparison of structures of StPbgA and EcPbgA. (a) StPbgA and EcPbgA are superimposed 
well. StPbgA colored in red, and EcPbgA colored in green. (b) Rotates 90° along y-axis relative to the left panel. 
Cα atoms of Loop S371-S360 moves away maximum of approximate 8 Å from of StPbgA to EcPbgA, strongly 
suggesting that this loop may involve in CL binding.
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F344A, W393D, and double mutants F399C/D372C and W397C/S395C did not have any impact on cell growth, 
strongly suggesting that these residues are not involved in the CL binding and transfer (Fig. 4h,i).
CL binding residues were further confirmed using CL co-sedimentation assays. Mutant proteins (F349A, 
R215A/R216A, F292A and F362A) of EcPbgA 191–586 were over-expressed and purified. Mutants F349A, 
R215A/R216A, F292A, F362A have reduced CL co-sedimentation compared to the wild type (Fig. 4J); this is con-
sistent with our functional assays, supporting that CL binding by these mutants is impaired. The F519A mutant 
forms an inclusion body so could not be assessed by CL co-sedimentation.
Potential CL-binding switch lid. Comparison of the crystal structures of EcPbgA245-586 and StPbgA245- 
586 revealed a conformational change of the loop between helices α 5 and α 6 (Fig. 2a). In EcPbgA245-586 this 
loop closes the hydrophobic core between the second (β -strands 1–8, α 8 and α 9) and third layers (α -helices 2, 4, 
5 and 10) and the residues P365-R368 form β -strand 4 to interact with β -strand 3, whereas the strand β 4 is disor-
dered and away from the hydrophobic core between the second and third layers in StPbgA245-586 (Figs 1b,c and 
2a). Residue F349 is solvent exposed and F362 is located in the hydrophobic core in EcPbgA245-586, while the 
residue F349 rotates toward the hydrophobic core and the F362 is solvent exposed in StPbgA245-586 (Fig. 4a,b). 
Analysis of the StPbgA245-586 structure revealed that there is a loop formed by residues D347-Q370 that has 
high B-factors between helices α 4 and α 6, indicating that this loop is flexible and may act as a lid for the CL 
binding and transport (Fig. 5a). To explore this possibility, we generated a double cysteine mutant S251C/D303C, 
which would lock the switch and significantly influence the CL binding. Indeed the mutant S251C/D303C 
impairs the cell growth (Fig. 4g).
Figure 3. PbgA structure is similar to arylsulfatase and lipoteichoic acid synthase, but do not contain the 
enzyme catalytic residues. (a) StPbgA (red) is superimposed to arylsulfatase (matanga). The arylsulfatase has 
additional α -helices and loops (cyan), forming the substrate binding “gate”. (b) Superimposition of StPbgA 
and arylsulfatase at the active site. (c) StPbgA (red) is superimposed to lipoteichoic acid synthase (yellow). (d) 
Superimposition of StPbgA and lipoteichoic acid synthase at the active site.
www.nature.com/scientificreports/
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Discussion
The OM of Gram-negative bacteria is an asymmetric membrane composed of phospholipids and lipopolysac-
charide. The lipids in the OM play important roles in the pathogenesis and drug resistance of Gram-negative 
bacteria. Despite the extensively studied LPS transport pathway in Gram-negative bacteria, the mechanisms for 
phospholipids transport and assembly in the OM remain to be characterized at the structural level.
CL plays an essential role in OM remodelling in bacteria and is critical for mitochondrial function41. PbgA 
transports CL from the IM to the OM in Gram-negative bacteria24. Mitochondria evolved from bacteria and the 
Figure 4. PbgA potential CL binding site. (a) the CL potential binding site between layers 2 and 3. The 
hydrophobic residues are colored in deep salmon. (b) Rotation 180° along y axis relative to the left panel.  
(c) Hydrophobic residues between layer 1 and 2 are colored in purple, which may do not involve in CL binding. 
(d) Rotation 180° along y axis relative to the left panel. (e–i) The functional assays of PbgA mutants and the 
drug resistance against 50 ug/ml vancomycin. (j) The CL binding assays were performed by co-sedimentation. 
All functional assays performed at least three times.
www.nature.com/scientificreports/
7Scientific RepoRts | 6:30815 | DOI: 10.1038/srep30815
UPS1/Mdm35 complex has been identified for phospholipid transfer from the OM to the IM in yeast. The recent 
structures of the UPS1 of yeast in complex with phospholipids have been determined29,30. The structure is quite 
different from those of PbgA with a RMSD of 3.7 Å over 62 Cα atoms (Fig. 6a,b). The UPS1 contains a concaved 
7-antiparellel stranded β -sheet, which wraps PA molecules inside the cavity. Only the long helix α 7 of PbgA is 
superimposed well with the helix α 3 of UPS1; the conformation of the β -sheet at the second layer of PbgA is 
different from that of the UPS1, which does not fold to form a cavity (Fig. 6a), indicating that this area between 
the first and second layers of PbgA may not be the CL binding site. Indeed, the functional assays using alanine 
substitution of aromatic residues between the first and the second layer showed that all the mutants did not 
impair bacterial growth, which suggest that the PbgA-mediated transport of CL is different from UPS1-mediated 
transport of PA in mitochondria.
The structure of EcPbgA245-586/StPbgA245-586 is strikingly similar to arylsulfatases and lipoteichoic acid 
synthases, but it lacks their enzymatic activities39. Metal ions, such as Mg2+, Mn2+ or Ca2+ are required for their 
catalytic function. Superimposition of PbgA structures over those of arylsulfatase and lipoteichoic acid synthase 
suggested that PbgA is unlikely to form the required metal ion-binding site found at the active sites of arylsulfa-
tase and lipoteichoic acid synthase.
The functional studies showed that single hydrophobic residue mutants F292A, F349A and F362A caused the 
cell death (Fig. 4e) or impaired cell growth in 50 μ g/ml vancomycin, indicating that these residues are involved in 
CL transport. This was further confirmed by the co-sedimentation assays (Fig. 4J). All these residues are located 
in the hydrophobic core between the layers 2 and 3 of PbgA245-586, strongly suggesting that this hydrophobic 
core is the potential CL binding site. Additionally, single mutant F344A, W393D, and double mutants F399C/
D372C and W397C/S395C between the first layer and the second layer did not have any influence on cell growth 
(Fig. 4h,i), which further confirms that the hydrophobic space between layer 2 and 3 may be responsible for the 
CL transport.
There is a significant conformational change of residues D347-Q370 between the EcPbgA245-586 and 
StPbgA245-586 (Fig. 2a), and these residues’ B-factors are higher than neighbouring residues (Fig. 5a), indicating 
Figure 5. Potential CL binding lid. (a) The PbgA loop consisting of residues D347-Q370 has higher B-factor 
comparing to the local residues, suggesting that the loop is flexible and may be a lid for the CL binding.  
(b) Cartoon representation of potential CL binding lid colored in yellow and the double cysteine mutation 
residues S351C/D303C may form a disulphide bond and prevent the lid to open for CL binding.
Figure 6. The PbgA structure is quite different from the UPS1 of mitochondria of yeast. (a) Only the long 
helix α 7 of PbgA is superimposed well with the helix α 3 of UPS1. (b) Rotation 180° along y axis relative to the 
left panel. DLPA, 1,2-dilauroyl-sn-glycero-3-phosphate (12:0–12:0).
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that they are flexible. We speculated that this region may be the lid for the CL binding, which can open to allow 
the CL access the binding site between the second and third layers. The double cysteine mutant S351C/D303C 
may form a disulphide bond and prevent the lid to open for CL binding (Fig. 5b). This mutant is lethal, suggesting 
that the loop may be the lid for the CL binding (Fig. 4g). The B-factors of the last α -helix 12 are also higher com-
pared to other local residues (Fig. 5a), indicating that this helix is flexible, which may suggest that it interacts with 
other proteins or OM components.
Phospholipid transport and assembly in the OM is a basic biological process. Our structural and functional 
studies have revealed that the hydrophobic core between the layer 2 and 3 may be the CL binding site and that 
the residues D347-Q370 may form a lid for the CL transport in the structures of PbgA245-586 of E. coli and S. 
typhinium, and. This is a first structure of a bacterial protein involved in phospholipid transport from the inner 
membrane to the OM. This work is important for understanding how bacteria pathogenesis and drug resistance 
is achieved by remodelling the OM, in addition to clarifying how Gram-negative bacteria assemble their OM.
Experimental Procedures
Cloning, expression, and purification of PbgA245–585. The pbgA gene (yejM) encoding PbgA245-
586 and PbgA191-586 from S. typhimurium strain LT2 and E. coli strain K-12 were amplified and inserted into 
plasmid pEHISTEV with a NcoI restriction sites at 5′ -end and EcoR1 sites at 3′ -end respectively. This plasmid 
includes a hexahistidine tag (6× His) and a tobacco etch virus (TEV) protease cleavage site between the Histag 
and the N-terminus of the cloned genes. The recombinant plasmids were transformed into soluble BL21(DE3) 
strain (Novagen) for protein expressions. The transformed soluble BL21(DE3) cells were grown in Luria broth 
(LB) supplemented with antibiotic (Kanamycin 50 μ g/ml) at 37 °C until the optical density of the culture reached 
0.5–0.8 at a wavelength of 600 nm (OD600nm). The proteins were induced by addition of 0.1 mM isopropyl β -d-thi-
ogalactopyranoside (IPTG) and incubated for 12 hours at 20 °C. For over-expression of selenomethionine (SeMet) 
labeled PbgA245-586, the protein was expressed in M9 medium supplemented with SeMet (Generon) to a final 
concentration of 100 μ g/ml using the methionine inhibition method42. The cells were harvested by centrifugation 
at 5000 × g for 20 mins, resuspended in buffer containing 20 mM Tris-Cl, pH 7.8, 10% glycerol and 500 mM 
NaCl, supplemented with cOmplete (Roche), 1 mM DNase (Sigma-Aldrich) and 1 mM phenylmethylsulphonyl 
fluoride (PMSF, Sigma-Aldrich). The cells were broken using a cell disruption at 30,000 psi (Constant Systems 
Ltd). The Cell debris was removed by centrifugation at 120,000 × g for 25 mins at 4 °C. The supernatant was then 
being loaded onto a nickel-nitrilotriacetate affinity resin column (Ni-NTA, Qiagen) and the column was washed 
with 20 mM Tris-Cl, pH 7.8, 500 mM NaCl, 30 mM imidazole and 10% glycerol. The recombinant proteins were 
eluted with 20 mM Tris-Cl, pH 7.8, 500 mM NaCl, 300 mM imidazole and 10% glycerol. The protein buffer was 
changed to 20 mM Tris-Cl, pH 7.8, 500 mM NaCl, 10% glycerol and 10 mM imidazole using a desalting column 
(Hi-PrepTM 26/10, GE Healthcare) to prevent protein precipitation. The (6 × His) tag was removed by TEV pro-
tease, and the PbgA protein was obtained by applying the samples through a Ni-NTA column. The protein was 
further purified using size exclusion chromatography with a HiLoad 16/60 Superdex 200 prep grade column (GE 
Healthcare) in a running buffer containing 20 mM Tris-Cl, pH 7.8 and 150 mM NaCl. Fractions with the highest 
purity of PbgA were pooled and concentrated to 10 mg/ml.
Crystallization and Data collection. Protein crystallization trails were performed using 1 μ l of protein 
mixed with 1 μ l of reservoir solution by the sitting-drop vapour diffusion technique at room temperature. The best 
crystals of SeMet incorporated StPbgA245-586 were obtained in 0.1 M Bis-tris pH 5.5 and 16% PEG3350. The 
best crystals of in EcPbgA245-586 were obtained in 0.2 M lithium sulphate, 0.1 M sodium acetate pH 4.3 and 48% 
PEG400. The best native crystals of StPbgA191-586 were obtained in 0.1 M Bis-tris pH 6.5 and 25% PEG3350. The 
crystals were harvested after 21 days and cryoprotected by supplementing the crystallization solution with 20% 
glycerol in the crystallization solutions, before being flash frozen in liquid nitrogen. Single-wavelength anomalous 
dispersion (SAD) data were collected at Diamond Light Source, UK at beam station I04. All data were processed 
using XDS43 and the StPbgA245-586 crystals that diffracted to 1.69 Angostram resolution belong to space group 
P21 with unit-cell dimensions: a = 52.6 Å, b = 196.09 Å, c = 70.27 Å and β = 95.79°. The native EcPbgA245-586 
crystal data were collected to 1.65 Å resolution and the crystals belong to space group P3121 with unit-cell dimen-
sions: a = 56.86 Å, b = 56.86 Å, c = 191.81 Å and γ = 120°.
Structure determination. The structure of StPbgA245-586 was solved by the SAD method using SHELX 
suite34. The initial model of the StPbgA245-586 was built automatically using the program Buccaneer36 with 
the phases obtained form the SHELX34. The native structure (Escherichia coli strain K-12) was determined by 
molecular replacement using structure from Salmonella as a search model using Phase44. The structures were 
manually built by using Coot37 and the structures were refined using REFMAC545. The structures were validated 
by Molprobity46. The statistics of the data collection and the structure refinement are summarized in Table 1.
Site-directed mutagenesis and functional assays. All single or double mutations were generated fol-
lowing the protocol47. The mutations were amplified by PCR using Q5® hot start high fidelity DNA polymerase 
(New England) and the pACYCDuet plasmid (Novagen), containing a C-terminal (6× His) tag of PbgA E. coli 
gene with an NcoI restriction site at the 5′ -end and Hind III site at the 3′ -end as the template for the pbgA 
mutagenesis.
The NRD183 strain still contains the transmembrane domain and only the periplasmic global domain is 
depleted. The NRD183 also contains a plasmid pNRD217, which carries the whole pbgA gene under pBAD con-
trol. As the NRD183 contains the N-terminal transmembrane domain, the strain is a conditional lethal strain. The 
strain is killed in presence of 50 ug/ml vancomycin without PbgA expression.
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The mutations were confirmed by DNA sequencing. Once the full length of the PbgA was shown to rescue 
the NRD183 strain, these single or double mutants were transformed into E. coli NRD18340, respectively. The 
transformed E. coli cells were grown on LB agar plate supplemented with antibiotics (kanamycin 50 μ g/ml, chlo-
ramphenicol 34 μ g/ml, and ampicillin 50 μ g/ml). Single colonies of each transformation was inoculated into 5 ml 
LB medium supplemented with above antibiotics and 0.2% L-arabinose. Subculture cells were used for functional 
assay. E. coli NRD183 with the empty plasmid pACYCDuet was used as a negative control. For functional assays, 
cells were harvested, washed one time and diluted in sterile LB medium to an absorbance (OD600 nm) of 0.5 and 
streaked onto LB agar plates supplemented with vancomycin 50 μ g/ml, kanamycin 50 μ g/ml and chloramphenicol 
34 μ g/ml and 5mM IPTG. Cell growths were recorded after overnight culture in 37 °C. All the assays have been 
repeated in triplicate.
Protein-Lipid co-sedimentation assays. Cardiolipins (CL) in chloroform (Sigma) was dried under 
nitrogen gas, and then re-suspended in 20 mM Tris (pH 7.8), and 150 mM NaCl. Subsequently, the CL was soni-
cated until the solution to be clear. The mixture (Lipid-protein) were incubated at 37 °C for 1 hour at a 10:1 molar 
ratio (20 mM: 2 mM), respectively following the reported method24. The reactions were centrifuged at 13.2 k rpm 
for 10 min. The supernatants were collected and the pellets were re-suspended in 20 μ l of buffer in 20 mM Tris 
(pH 7.8), and 150 mM NaCl. The pellets (10 μ l) and supernatants (10 μ l) were boiled in the SDS-containing sam-
ple buffer and separated on 12% SDS Tris-HCl PAGE. The proteins were visualized by Coomassie staining.
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